|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02373 BEAUTYFARM MED
Nominal 
19.950 -0.210 (-1.042%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 3,000,539 | 16.653% | 2,572,199 | 2,145,068 | 1,635,414 | 1,780,740 |
| Cost of Sales | (1,528,657) | 10.596% | (1,382,204) | (1,167,966) | (917,572) | (946,954) |
| Gross Profit | 1,471,882 | 23.688% | 1,189,995 | 977,102 | 717,842 | 833,786 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,809) | -7.018% | (3,021) | (796) | (155) | (1,306) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (51) | 0 | 0 | |
| Profit / (Loss) before Taxation | 450,066 | 41.582% | 317,883 | 288,269 | 130,475 | 255,102 | |
| Taxation | (109,791) | 67.863% | (65,405) | (58,130) | (19,943) | (46,761) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (22,713) | -5.433% | (24,018) | (14,482) | (7,423) | (14,866) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 317,562 | 39.001% | 228,460 | 215,657 | 103,109 | 193,475 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,450 | 139.787% | 3,941 | 2,974 | 21,619 | 22,933 |
| Depreciation & Amortisation | -- | -- | 382,577 | 331,736 | 297,241 | 275,188 |
| Directors' Emoluments | -- | -- | 3,819 | 3,244 | 6,124 | 4,381 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 138.000 | 39.394% | 99.000 | 94.000 | 52.000 | -- |
| DPS (cts) | 63.000 | -- | 48.000 | 43.000 | 34.000 | -- |
| Dividend Payout Ratio (%) | 45.652% | -- | 48.485% | 45.745% | 65.385% | -- |
| Cash flow per share ($) | -- | -- | 3.469 | 2.736 | 1.911 | -- |
| NBV per share ($) | 4.352 | -- | 4.006 | 3.392 | -- | -- |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 317,562 |
| %Change | 39.001% |
| EPS / (LPS) | RMB 1.380 |
| NBV Per Share (¥) | RMB 4.352 |